Metabolic syndrome and its components predict the development of arterial stiffening in a sample of adult men
暂无分享,去创建一个
F. Galletti | P. Strazzullo | L. D’elia | R. Iacone | A. Barbato | O. Russo
[1] F. Galletti,et al. Relationship between circulating leptin levels and arterial stiffness: a systematic review and meta-analysis of observational studies , 2020, High Blood Pressure & Cardiovascular Prevention.
[2] F. Viazzi,et al. Increased serum uric acid levels are associated to renal arteriolopathy and predict poor outcome in IgA nephropathy. , 2020, Nutrition, metabolism, and cardiovascular diseases : NMCD.
[3] E. Schiffrin,et al. Vascular consequences of inflammation: a position statement from the ESH Working Group on Vascular Structure and Function and the ARTERY Society. , 2020, Journal of hypertension.
[4] G. Grassi,et al. Association between uric acid and pulse wave velocity in hypertensive patients and in the general population: a systematic review and meta-analysis , 2020, Blood pressure.
[5] R. Facchetti,et al. THE role of metabolic syndrome in blood pressure control and pulse wave velocity progression over a 3.5 years in treated hypertensive PATIENTS. , 2020, European journal of internal medicine.
[6] F. Galletti,et al. Circulating leptin is associated with serum uric acid level and its tubular reabsorption in a sample of adult middle-aged men , 2019, Journal of Endocrinological Investigation.
[7] G. Lip,et al. Guidelines for the management of arterial hypertension of the European Society of Hypertension and the European Society of Cardiology : ESH / ESC Task Force for the Management of Arterial Hypertension , 2019 .
[8] S. Laurent,et al. Interaction Between Hypertension and Arterial Stiffness: An Expert Reappraisal , 2018, Hypertension.
[9] G. Parati,et al. Validation of an easy questionnaire on the assessment of salt habit: the MINISAL-SIIA Study Program , 2018, European Journal of Clinical Nutrition.
[10] E. Schiffrin,et al. Role of immune cells in hypertension , 2018, British journal of pharmacology.
[11] G. Mancia,et al. Uric acid and risk of new-onset metabolic syndrome, impaired fasting glucose and diabetes mellitus in a general Italian population: data from the Pressioni Arteriose Monitorate E Loro Associazioni study , 2018, Journal of hypertension.
[12] Zhiheng Chen,et al. The comorbidity of increased arterial stiffness and microalbuminuria in a survey of middle-aged adults in China , 2018, BMC Cardiovascular Disorders.
[13] A. Avolio,et al. Smooth muscle cell and arterial aging: basic and clinical aspects , 2018, Cardiovascular research.
[14] P. Strazzullo,et al. Excess Body Weight, Insulin Resistance and Isolated Systolic Hypertension: Potential Pathophysiological Links , 2018, High Blood Pressure & Cardiovascular Prevention.
[15] L. D’elia,et al. Effect of statin therapy on pulse wave velocity: A meta-analysis of randomized controlled trials , 2018, Clinical and experimental hypertension.
[16] A. de la Sierra,et al. Effects of metabolic syndrome on arterial function in different age groups: the Advanced Approach to Arterial Stiffness study , 2018, Journal of hypertension.
[17] F. Galletti,et al. Effect of dietary sodium restriction on arterial stiffness: systematic review and meta-analysis of the randomized controlled trials , 2017, Journal of hypertension.
[18] R. Hegele,et al. The apolipoprotein C-III (Gln38Lys) variant associated with human hypertriglyceridemia is a gain-of-function mutation[S] , 2017, Journal of Lipid Research.
[19] P. Challande,et al. SRF/myocardin: a novel molecular axis regulating vascular smooth muscle cell stiffening in hypertension. , 2017, Cardiovascular research.
[20] S. Studenski,et al. Longitudinal Association Between Serum Uric Acid and Arterial Stiffness: Results From the Baltimore Longitudinal Study of Aging , 2017, Hypertension.
[21] F. Galletti,et al. The Olivetti Heart Study: Predictive value of a new adiposity index on risk of hypertension, blood pressure, and subclinical organ damage. , 2016, Nutrition, metabolism, and cardiovascular diseases : NMCD.
[22] V. Gudnason,et al. Pulse Pressure Relation to Aortic and Left Ventricular Structure in the Age, Gene/Environment Susceptibility (AGES)-Reykjavik Study , 2014, Hypertension.
[23] N. Ewald,et al. Current knowledge of hypertriglyceridemic pancreatitis. , 2014, European journal of internal medicine.
[24] A. Tedgui,et al. Adaptive (T and B Cells) Immunity and Control by Dendritic Cells in Atherosclerosis , 2014, Circulation research.
[25] J. Coresh,et al. GFR estimation: from physiology to public health. , 2014, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[26] A. Hofman,et al. Arterial stiffness and influences of the metabolic syndrome: a cross-countries study. , 2014, Atherosclerosis.
[27] F. Galletti,et al. Not smoking is associated with lower risk of hypertension: results of the Olivetti Heart Study. , 2014, European journal of public health.
[28] Daniel F. Freitag,et al. Inflammatory cytokines and risk of coronary heart disease: new prospective study and updated meta-analysis. , 2014, European heart journal.
[29] A. Cote,et al. Childhood obesity and cardiovascular dysfunction. , 2013, Journal of the American College of Cardiology.
[30] R. Touyz,et al. Angiotensin II, NADPH oxidase, and redox signaling in the vasculature. , 2013, Antioxidants & redox signaling.
[31] S. Kardia,et al. Metabolic syndrome is associated with change in subclinical arterial stiffness - A community-based Taichung Community Health Study , 2011, BMC public health.
[32] Sung-il Cho,et al. Risks for cardiovascular disease, stroke, ischaemic heart disease, and diabetes mellitus associated with the metabolic syndrome using the new harmonised definition: findings from nationally representative longitudinal data from an Asian population. , 2010, Atherosclerosis.
[33] A. Levin,et al. Matrix metalloproteinase-2 and -9 exacerbate arterial stiffening and angiogenesis in diabetes and chronic kidney disease. , 2009, Cardiovascular research.
[34] S. Grundy,et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International As , 2009, Circulation.
[35] G. Mancia,et al. The metabolic syndrome in hypertension: European society of hypertension position statement , 2008, Journal of hypertension.
[36] E. Meaney,et al. METFORMIN, ARTERIAL FUNCTION, INTIMA–MEDIA THICKNESS AND NITROXIDATION IN METABOLIC SYNDROME: THE MEFISTO STUDY , 2008, Clinical and experimental pharmacology & physiology.
[37] F. Cappuccio,et al. Diagnostic criteria for metabolic syndrome: a comparative analysis in an unselected sample of adult male population. , 2008, Metabolism: clinical and experimental.
[38] H. Makino,et al. Uric acid stimulates vascular smooth muscle cell proliferation and oxidative stress via the vascular renin–angiotensin system , 2008, Journal of hypertension.
[39] B. Davis,et al. Clinical outcomes by race in hypertensive patients with and without the metabolic syndrome: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). , 2008, Archives of internal medicine.
[40] F. Cappuccio,et al. Circulating leptin levels predict the development of metabolic syndrome in middle-aged men: an 8-year follow-up study , 2007, Journal of hypertension.
[41] H. Hashimoto,et al. The Effects of Changes in the Metabolic Syndrome Detection Status on Arterial Stiffening: A Prospective Study , 2006, Hypertension Research.
[42] B. Pannier,et al. Metabolic syndrome and age-related progression of aortic stiffness. , 2006, Journal of the American College of Cardiology.
[43] In-kyu Lee,et al. Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells. , 2005, Journal of the American Society of Nephrology : JASN.
[44] G. Doronzo,et al. Insulin activates vascular endothelial growth factor in vascular smooth muscle cells: influence of nitric oxide and of insulin resistance , 2004, European journal of clinical investigation.
[45] Pasquale Strazzullo,et al. Altered Renal Handling of Sodium in Human Hypertension: Short Review of the Evidence , 2003, Hypertension.
[46] Arya M. Sharma,et al. Hormonal regulation of the human adipose-tissue renin–angiotensin system: relationship to obesity and hypertension , 2002, Journal of hypertension.
[47] D. Kass,et al. Improved Arterial Compliance by a Novel Advanced Glycation End-Product Crosslink Breaker , 2001, Circulation.
[48] J D Swales,et al. Effect of Aging on the Prognostic Significance of Ambulatory Systolic, Diastolic, and Pulse Pressure in Essential Hypertension , 2001, Circulation.
[49] R. Asmar,et al. Reference values for clinic pulse pressure in a nonselected population. , 2001, American journal of hypertension.
[50] A. Bihorac,et al. Association between salt sensitivity and target organ damage in essential hypertension. , 2000, American journal of hypertension.
[51] S. Yamashita,et al. Effect of visceral fat accumulation on uric acid metabolism in male obese subjects: visceral fat obesity is linked more closely to overproduction of uric acid than subcutaneous fat obesity. , 1998, Metabolism: clinical and experimental.
[52] P. Guillausseau,et al. Diabetes, advanced glycation endproducts and vascular disease , 1998, Vascular medicine.
[53] M. Daemen,et al. Effects of Chemical Sympathectomy on Angiotensin II-Induced Neointimal Growth in the Balloon-Injured Rat Carotid Artery , 1998, Journal of Vascular Research.
[54] G. Dagenais,et al. Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Québec Cardiovascular Study. , 1997, Circulation.
[55] F. Yin,et al. Short- and long-term effects of antihypertensive drugs on arterial reflections, compliance, and impedance. , 1995, Hypertension.
[56] R. Havel,et al. Triglyceride-rich lipoproteins isolated by selected-affinity anti-apolipoprotein B immunosorption from human atherosclerotic plaque. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.
[57] S. Azen,et al. Triglyceride‐ and Cholesterol‐Rich Lipoproteins Have a Differential Effect on Mild/Moderate and Severe Lesion Progression as Assessed by Quantitative Coronary Angiography in a Controlled Trial of Lovastatin , 1994, Circulation.
[58] M. Safar,et al. Endothelium-dependent mechanical properties of the carotid artery in WKY and SHR. Role of angiotensin converting enzyme inhibition. , 1990, Circulation research.
[59] H. Halkin,et al. Elevated serum uric acid — a facet of hyperinsulinaemia , 1987, Diabetologia.
[60] G. Mancia,et al. Metabolic syndrome and subclinical carotid damage: a meta-analysis from population-based studies , 2018, Journal of hypertension.